Careers  |  Sign In  |  Register  |   Twitter

Optimizing Outcomes in Diabetes

It

Stephen Brunton, MD, Director of Faculty Division, Cabarrus Family Medicine, Charlotte, North Carolina, discusses recent clinical trials and the role of blood pressure, lipid and glycemic control in patients with diabetes.

References and Resources
Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR.
Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 2006 Aug;49(8):1761-9. Epub 2006 May 31.
Click Here to read abstract.

Davis BR, Piller LB, Cutler JA, et al; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation. 2006 May 9;113(18):2201-10. Epub 2006 May 1.
Click Here to read the article.

Bakris GL, Fonseca V, Katholi RE, et al; GEMINI Investigators.
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes. Hypertension. 2005 Dec;46(6):1309-15. Epub 2005 Nov 14.
Click Here to read the article.

Click Here to download a copy of the JNC 7 Express Highlights.

Dr. Brunton has disclosed the following:
Consulting Fees: Pfizer, Novo Nordisk, Amylin, Takeda, Novartis

Sponsored by The Doctor’s Channel